MwanzoALTME • EPA
add
TME Pharma NV
Bei iliyotangulia
€ 0.13
Bei za siku
€ 0.13 - € 0.14
Bei za mwaka
€ 0.13 - € 1.41
Thamani ya kampuni katika soko
6.76M EUR
Wastani wa hisa zilizouzwa
elfu 503.78
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
EPA
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (EUR) | Des 2023info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | — | — |
Matumizi ya uendeshaji wa biashara | 1.42M | -33.74% |
Mapato halisi | -1.54M | 35.96% |
Kiwango cha faida halisi | — | — |
Mapato kwa kila hisa | — | — |
EBITDA | -1.41M | 33.94% |
Asilimia ya kodi ya mapato | -0.07% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (EUR) | Des 2023info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 2.24M | -51.55% |
Jumla ya mali | 2.49M | -52.47% |
Jumla ya dhima | 2.78M | -57.24% |
Jumla ya hisa | elfu -294.00 | — |
hisa zilizosalia | 17.28M | — |
Uwiano wa bei na thamani | -6.73 | — |
Faida inayotokana na mali | -142.51% | — |
Faida inayotokana mtaji | -407.11% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (EUR) | Des 2023info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -1.54M | 35.96% |
Pesa kutokana na shughuli | -1.12M | 64.34% |
Pesa kutokana na uwekezaji | 0.00 | 100.00% |
Pesa kutokana na ufadhili | elfu 738.00 | -48.54% |
Mabadiliko halisi ya pesa taslimu | elfu -381.50 | 77.28% |
Mtiririko huru wa pesa | elfu -756.56 | 35.57% |
Kuhusu
TME Pharma, formerly NOXXON Pharma, is a biotechnology company founded in 1997 in Berlin, Germany which specialises on cancer treatment by targeting the tumor microenvironment. TME Pharma N.V. is listed on Euronext Growth, Paris and is a member of the German Association of Research-Based Pharmaceutical Companies, Verband forschender Arzneimittelhersteller.
TME Pharma develops drugs using technology yielding L-RNA molecules, which are of mirror-image configuration compared to naturally occurring D-RNA molecules. The company calls these agents Spiegelmers, from Spiegel, the German word for "mirror."
The L-RNA are resistant to the natural RNA nuclease enzymes. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1997
Tovuti
Wafanyakazi
13
